Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV

Clinical trial NCT06873633 · RECRUITING

Trial details

NCT number: NCT06873633
Sponsor: PENTA Foundation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2025-07-16
Primary completion: 2026-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.